Finally, anatomical and behavioral deficits in a mouse model of Down syndrome have also reportedly been corrected by a single injection with an Shh signaling pathway agonist (SAG) at birth, suggesting that temporary Shh pathway activation could lead to long-term modulation of brain development and functions [103]. The gene discussed is SHH; the disease is Down syndrome.